Yan Wang
About Yan Wang
Yan Wang is the Sr. Director of Translational Medicine at Alkermes with over two decades of experience in oncology and immuno-oncology.
Title and Current Role
Yan Wang currently serves as the Senior Director of Translational Medicine at Alkermes, based in Waltham, MA. In this role, Wang is responsible for leading efforts in translational medicine, including the development of clinical biomarkers. Wang has been with Alkermes since January 2019, focusing on oncology and immuno-oncology.
Previous Industry Experience
Yan Wang has amassed over two decades of experience in the pharmaceutical industry. Prior to joining Alkermes, Wang held several key leadership roles. From 2016 to 2019, Wang was the Senior Director of Translational Research at X4 Pharmaceuticals in Cambridge, MA. Between 2015 and 2016, Wang served as the Director of Biology at Verastem in Needham, MA. From 2013 to 2015, Wang worked as the Director of Scientific R&D at TESARO. Earlier in their career, Wang spent significant time at Merck Research Lab as the Collaboration Lead for Oncology and Discovery and Pre-Clinical Sciences from 2009 to 2012.
Academic Background
Yan Wang's educational background is rooted deeply in molecular biology and biochemistry. Wang earned a Ph.D. in Molecular Biology from Princeton University, where they studied from 1986 to 1992. Before that, Wang completed a Bachelor's degree in Biochemistry at Peking University. Additionally, Wang engaged in postdoctoral research at Columbia University from 1992 to 1995.
Early Career and Research
Yan Wang began their career as a Senior Research Scientist at IDUN Pharmaceuticals, a role they held from 1996 to 1999. Subsequently, Wang joined Schering-Plough Research Institute as a Fellow, a position Wang held for a decade from 1999 to 2009. These roles equipped Wang with valuable experience in pre-clinical and early-stage research in oncology.
Expertise in Oncology and Immuno-Oncology
Yan Wang is recognized for their extensive expertise in oncology and immuno-oncology. This includes significant experience in the development of clinical biomarkers. Throughout Wang's career, they have successfully led cross-functional teams in drug discovery and development projects, contributing to notable advancements in oncology research.